IASO PHARMA
IASO Pharma Inc. is a development stage company focusing on development of therapeutics for the treatment and prevention of infectious diseases. It offers antibiotics. The company was formerly known as Pacific Beach Biosciences, Inc. and changed its name in April, 2010. It was founded in 2006 and is based in San Diego, California.
IASO PHARMA
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2006-01-01
Address:
San Diego, California, United States
Country:
United States
Total Employee:
11+
Status:
Active
Total Funding:
3.34 M USD
Current Employees Featured
More informations about "IASO Pharma"
IASO，IASO Bio，IASO Biotherapeutics，IASO …
IASO，IASO Bio，IASO Biotherapeutics，IASO Biopharma，CT103A， CAR-T， cell therapy，dual-targeted CAR-T. HOME; ABOUT IASO. Overview; Management Team ... IASO …See details»
IASO Pharma - Crunchbase Company Profile & Funding
IASO Pharma Inc. is a development stage company focusing on development of therapeutics for the treatment and prevention of infectious diseases. It offers antibiotics. The company was …See details»
Next Generation Vaccines - Iaso Therapeutics
Iaso Therapeutics is dedicated to developing next generation vaccines to enhance human health and treat diseases. Mutant Qβ Platform. Iaso’s initial product offering is a disruptive new virus …See details»
Overview / ABOUT IASO / IASO，IASO Bio，IASO …
Founded in 2017, IASO Bio is a leading biopharmaceutical company specializing in the discovery, development, manufacturing, and commercialization of cutting-edge cell therapies and …See details»
IASO Pharma Inc. Company Profile | San Diego, CA | Competitors ...
Company Description: IASO Pharma aims to cure what ails ya. The development-stage drug company focuses on in-licensing potential treatments for bacterial and fungal infections. Its …See details»
IASO Biotherapeutics - Crunchbase Company Profile & Funding
IASO Biotherapeutics may be growing as it has recently achieved a significant regulatory milestone and secured substantial venture funding. The company, in collaboration with …See details»
IASO BIO Announces New Development Partnership with Umoja …
IASO Bio is a biopharmaceutical company engaged in the discovery and development of novel cell therapies and biologics for oncology and autoimmune diseases. IASO Bio possesses …See details»
IASO Pharma - Funding, Financials, Valuation & Investors
IASO Pharma is a development stage company developing therapeutics for the treatment and prevention of infectious diseases. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Organization | IASO Pharma Inc.
IASO Pharma Inc. Report issue. For profit Phase 1 Phase 2 Phase 3. Founded: San Diego CA United States (2006) Status: Acquired by Eli Lilly (1990 ...See details»
IASO Biotherapeutics’ Equecabtagene Autoleucel, the World’s First …
May 20, 2022 Relying on its management team with strong execution, rich product pipeline, unique innovative R&D and business model, IASO Bio is determined to grow into an influential …See details»
IASO Pharma, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore IASO Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Drug:PB-200a.See details»
IASO Biotherapeutics - VentureRadar
Founded in March 2017, IASO BIO is engaged in the development and industrialization of tumor cell immunotherapy drugs. Launched in Nanjing Biotech and Pharmaceutical Valley, the …See details»
IASO Bio Raises Nearly $75 Million in Series C1 Funding - PR …
Jan 18, 2023 NANJING and SHANGHAI, China and SAN JOSE, Calif., Jan. 17, 2023 /PRNewswire/ -- IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical …See details»
Umoja Biopharma and IASO Biotherapeutics Announce Research ...
SEATTLE, SAN JOSE, Calif., SHANGHAI, NANJING, China, November 21, 2022 – Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated …See details»
IASO Bio Announces Approval of New Drug Application for …
5 days ago IASO Bio Announces Approval of New Drug Application for Equecabtagene Autoleucel by the Macau Pharmaceutical Administration Bureau PR Newswire Fri, Mar 28, …See details»
IASO Biotherapeutics Secures $108 Million Series C Funding to …
September 16, 2021, PLEASANTON, Calif. & NANJING, SHANGHAI, China – IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company focusing on …See details»
IASO THERAPEUTICS, INC. - National Science Foundation
Dive into the research topics where IASO THERAPEUTICS, INC. is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint. …See details»
IASO Biotherapeutics and Cabaletta Bio Announce Exclusive …
Oct 11, 2022 IASO Bio owns many technology platforms, including a fully human antibody discovery platform, a high-throughput CAR-T drug preference platform, a general CAR …See details»
IASO Pharma - Contacts, Employees, Board Members, Advisors
IASO Pharma is a development stage company developing therapeutics for the treatment and prevention of infectious diseases. New. Resources. Advanced Search. Start Free Trial . Talk …See details»
Home - IASO Pharmaceuticals
IASO Pharmaceuticals – your trusted partner in skincare & aesthetic medicine. ISO 9001: 2015 Certified GMP Certified Value For money Experienced Team Quality Is our #1 priority …See details»